Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Allow Innovative Progressions To have a Massive Effect - 2Expert advice for new stargazers: How to begin your amateur astronomy journey
- 35 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- 46 Modest and Strong Tire Brands
- 5Hilary Duff releases 'Mature,' her 1st song in 10 years
- A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
- The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- Vote in favor of the Top Vegetable for Senior
- UN chief warns he could refer Israel to ICJ over laws targetting UNRWA
- Opening Innovativeness: Moving Thoughts and Tasks
- Who was Haytham Ali Tabatabai, Hezbollah's military leader killed by Israel?
- Pick Your #1 Sort Of Espresso
- In blow to Lula, Brazil Congress revives controversial environmental bill
- Incredible Travel Objections for Craftsmanship Darlings to Visit
